Table 3.
Factors associated with survival of all patients
| Factors |
Univariate |
Multivariate |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | P | HR | 95% CI | P | |
| Without BD induction |
4.730 |
1.003-22.307 |
0.050 |
4.359 |
0.913-20.823 |
0.065 |
| Urine protein >3.5 g/24 hour |
1.2 |
0.310-4.647 |
0.792 |
|
|
|
| Cardiac stage III |
4.118 |
1.138-14.899 |
0.031 |
1.272 |
0.276-5.864 |
0.758 |
| Baseline BNP >170 ng/L |
2.837 |
0.814-9.892 |
0.104 |
|
|
|
| Troponin-I >0.03 |
6.494 |
1.673-25.213 |
0.007 |
6.138 |
1.559-24.170 |
0.009 |
| The use of MEL 140 | 3.445 | 0.730-16.255 | 0.118 | |||
BD, bortezomib in combination wity dexamethasone; BNP, brain natriuretic peptide; CI, confidence interval; HR, hazard ratio; MEL, melphalan.